title: Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor.
abstract: Since it was discovered that the hematopoietic hormone erythropoetin (EPO) exerts neuroprotective effects in the CNS, many studies on the EPO receptor (EPOR) function and localisation in the CNS have been performed. For this purpose, commercially available anti-EPOR antibodies have often been applied. As the literature data on these antibodies show inconsistencies, we here systematically compared six frequently used, commercially available EPOR antibodies for different applications. Five of the antibodies appeared to specifically recognize recombinant rat and human EPOR in HEK293 cells by Western blotting, but the same antibodies yielded different and inconsistent results when human UT-7 cells or rat brain tissue were applied. Immunocytochemical staining of EPOR-transfected HEK cells only produced consistent results with three of the six antibodies. All antibodies stained neurons in rat brain sections, but with large differences in the staining pattern and only the C-20 EPOR antibody was found to label astrocytes. Since EPOR antibodies have been applied in several studies as EPOR antagonists, we further tested the antibodies for their capacity to functionally block the EPO-EPOR interaction in a cellular signalling system with STAT-5 phosphorylation as readout. Here, only the MAB307 antibody showed a partial effect at concentrations of 5-50 microg/ml.
authors.affiliation: Department of Molecular Neurobiology, H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark. agki@lundbeck.com
authors.forename: Agnete
authors.initials: A
authors.lastname: Kirkeby
authors.forename: Johan
authors.initials: J
authors.lastname: van Beek
authors.forename: Jacob
authors.initials: J
authors.lastname: Nielsen
authors.forename: Marcel
authors.initials: M
authors.lastname: Leist
authors.forename: Lone
authors.initials: L
authors.lastname: Helboe
mesh_terms: D000818:Animals; D000906:Antibodies / Q000494:pharmacology*; D000918:Antibody Specificity / Q000276:immunology*; D015415:Biomarkers / Q000032:analysis / Q000378:metabolism; D015153:Blotting, Western / Q000379:methods; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods*; D009448:Neurochemistry / Q000379:methods*; D010766:Phosphorylation / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D017467:Receptors, Erythropoietin / Q000032:analysis* / Q000235:genetics / Q000276:immunology*; D050799:STAT5 Transcription Factor / Q000187:drug effects / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology; D013194:Staining and Labeling / Q000379:methods
chemical_list: D000906:Antibodies; D015415:Biomarkers; D017467:Receptors, Erythropoietin; D050799:STAT5 Transcription Factor; D004921:Erythropoietin